Advertisement
Australia markets open in 9 hours 44 minutes
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • AUD/USD

    0.6500
    0.0000 (-0.00%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • OIL

    82.41
    -0.40 (-0.48%)
     
  • GOLD

    2,331.50
    -6.90 (-0.30%)
     
  • Bitcoin AUD

    98,028.61
    -3,664.91 (-3.60%)
     
  • CMC Crypto 200

    1,373.20
    -9.37 (-0.68%)
     

New Strong Buy Stocks for July 17th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Delta Air Lines, Inc. (DAL): This company that provides scheduled air transportation for passengers and cargo has seen the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.

Delta Air Lines, Inc. Price and Consensus

 

Delta Air Lines, Inc. Price and Consensus
Delta Air Lines, Inc. Price and Consensus

Delta Air Lines, Inc. price-consensus-chart | Delta Air Lines, Inc. Quote

Sunoco LP (SUN): This company that engages in the distribution and retailing of motor fuels has seen the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.

ADVERTISEMENT

Sunoco LP Price and Consensus

 

Sunoco LP Price and Consensus
Sunoco LP Price and Consensus

Sunoco LP price-consensus-chart | Sunoco LP Quote

Alexion Pharmaceuticals, Inc. (ALXN): This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 0.1% over the last 60 days.

Alexion Pharmaceuticals, Inc. Price and Consensus

 

Alexion Pharmaceuticals, Inc. Price and Consensus
Alexion Pharmaceuticals, Inc. Price and Consensus

Alexion Pharmaceuticals, Inc. price-consensus-chart | Alexion Pharmaceuticals, Inc. Quote

Exelixis, Inc. (EXEL): This oncology-focused biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 1.1% over the last 60 days.

Exelixis, Inc. Price and Consensus

 

Exelixis, Inc. Price and Consensus
Exelixis, Inc. Price and Consensus

Exelixis, Inc. price-consensus-chart | Exelixis, Inc. Quote

Hologic, Inc. (HOLX): This medical technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 90 days.

Hologic, Inc. Price and Consensus

 

Hologic, Inc. Price and Consensus
Hologic, Inc. Price and Consensus

Hologic, Inc. price-consensus-chart | Hologic, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Sunoco LP (SUN) : Free Stock Analysis Report
 
Hologic, Inc. (HOLX) : Free Stock Analysis Report
 
Exelixis, Inc. (EXEL) : Free Stock Analysis Report
 
Delta Air Lines, Inc. (DAL) : Free Stock Analysis Report
 
Alexion Pharmaceuticals, Inc. (ALXN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research